Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

IMAX Corporation (USA) (IMAX), Regal Entertainment Group (RGC): The Canadian Stock Investors Need to Keep an Eye On

Editor’s Note: This article has been amended to remove a section that was both incorrect and outdated. Motley Fool apologizes for the error.

Motion pictures are a big business and Hollywood alone clocks an average annual turnover of $11 billion. IMAX Corporation (USA) (NYSE:IMAX) was quick to recognize the potential in the business and brought in a technology which truly revolutionized the entire movie experience.

IMAX Corporation (USA) (NYSE:IMAX)The IMAX system has its roots in EXPO ’67 in Montreal, Canada where multi-screen films are a hit. A small group of Canadian filmmakers and entrepreneurs decide to design a new system using a single, powerful projector, rather than the multiple projectors used at that time. The result: the IMAX Corporation (USA) (NYSE:IMAX) motion picture projection system, which revolutionized cinema. Over the years, IMAX continued to move along the path of innovation and brought in a resurgence of 3D technology into mainstream cinema in the late 80’s.

IMAX posted robust revenue and profits for fiscal year 2012, generating revenue of $280, which is a 21% jump from last year. IMAX realizes that in order to maintain high growth, it has to look beyond the American shores and with this clear and focused intent, it has continued to expand its footprint in the overseas market. The company identifies APAC, Europe, and Latin America as its major foreign markets.

New markets

China has been on the company’s radar for quite some time, and it is evident from the company’s annual report for the fiscal 2012, which suggests that China is its largest market outside America. In order to further penetrate the Chinese movie market, the company entered into a landmark 75 theater revenue sharing deal with China’s Wanda Cinema Line which is the firm’s largest deal outside the American market.

The introduction of the joint revenue sharing agreement has led to a significant increase in the company’s theater penetration across the globe. This has enabled the company ink deals with major filmmakers and theaters to push the IMAX experience and develop a market in new areas.

A closer analysis of the company’s financials reveals a similar mood in the market with a forward P/E (FYE 2014) pegged at 20.42 compared to current P/E of 42.55. Moreover, a PEG ratio of 0.9 vividly exhibits there is a broad consensus of future earnings growth for the company.

Competitive scenario

IMAX, with its patented revolutionary technology, operates in a space with virtually no direct competitors, as IMAX provides technology to both theater companies and filmmakers for an enhanced movie experience. However, the company faces emerging competition from North America’s largest theater group, the Regal Entertainment Group (NYSE:RGC) and Cinemark Holdings, Inc. (NYSE:CNK), which offer cinema goers an impressive experience at relatively cheaper prices.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.